**1. Business Performance:** Entero Healthcare delivered a strong Q1FY27. Consolidated revenue surged 40% YoY (like-for-like) to ₹1,940 Cr, outperforming industry growth.

Profitability soared with EBITDA margin at 5.0% (+143bps YoY) and PAT margin at 2.7%. Return ratios impressed: ROCE nearly doubled to 21.1% and ROE was 20.4%. **2. Growth Drivers or Strategy:** Strategic focus on the high-growth MedTech market, with FY27 revenue projected to cross ₹1,000 Cr.

Its unique demand fulfillment & generation model, powered by proprietary tech, drives efficiency and leverages market consolidation via acquisitions. **3. Recent Developments:** No new acquisitions this quarter; the company focused on organic growth and optimizing operations by strategically exiting low-margin segments. **4. Key Financial Metrics:** Q1FY27 Revenue: ₹1,940.5 Cr | PAT: ₹52.1 Cr | Basic EPS: ₹8.77. Gross margin improved to 11.4% (+147bps YoY); Net Working Capital (NWC) days improved to 61. **5. Management Commentary / Outlook:** Management is highly confident about achieving its annual guidance, viewing Q1's strong performance as a solid foundation for sustained momentum.